Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
16 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
HepaVue Dx from Waterloo, company number BE0803100414, closed financial year 2025 with a result of € -351,134 after tax. For that financial year HepaVue Dx recorded a gross margin of € -299,924 and equity of € 429,994. Compared with financial year 2024, the result moved from € -42,023 to € -351,134. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 429,994
▲ € 452,017 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -351,134
▼ 736 % more loss than in 2024
Profit after tax over the fiscal year.
€ 1.1 million
▲ 162% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -393,157.
People and assets in 2025
€ 68,646
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,590
▼ 27% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2.5 million
▲ € 2.1 million vs 2024
Loans from banks and other lenders, long and short.
€ 184,903
▲ € 177,468 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,535
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -41,383 | € -299,924 | ▼ € 258,541 |
| Profit after taxes | € -42,023 | € -351,134 | ▼ € 309,110 |
| Equity | € -22,023 | € 429,994 | ▲ € 452,017 |
| Total debts | € 677,512 | € 3,280,710 | ▲ € 2.6 million |
| Cash | € 433,565 | € 1,136,686 | ▲ 162% |
| Retained profit | € -42,023 | € -393,157 | ▼ € 351,134 |
| Bank debt | € 450,000 | € 2,525,500 | ▲ € 2.1 million |
| Balance sheet total | € 655,488 | € 3,710,704 | ▲ € 3.1 million |
Key figures of HepaVue Dx, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to HepaVue Dx?
What happened at HepaVue Dx in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 351,134. filed late Source: NBB ↗
- Maxime NACHIT became a director. NBB
- New establishment in Waterloo. KBO
- Start of the company according to the CBE. KBO
In short
From € 42,023 loss in 2024 to € 351,134 loss in 2025.
A new publication or filing at HepaVue Dx? We notify you, reason included.
Follow HepaVue DxDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Maxime NACHIT
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Drève Richelle 161M box 57
1410 Waterloo
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
All companies at this address →MATERIAL
€ 60,907 gross margin · 2025
ENERGIEBEL
€ -15,804 gross margin · 2024
CALL INTERNATIONAL
€ -49,939 gross margin · 2025
POWER FOR SALES
€ 36,429 revenue · 2024
INTERPART IMPEX
€ 196,043 gross margin · 2024
+11 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0803.100.414
- VAT number
- BE 0803.100.414
- Registered office
- Drève Richelle 161M bus 57, 1410 Waterloo
- Names & denominations
- HepaVue Dx
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 June 2023
- Peppol
- Active · Active since 12 Nov 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied